{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:56:15Z","timestamp":1772607375235,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Laboratory and Clinical Medicine"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1067\/mlc.2002.121551","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"147-154","source":"Crossref","is-referenced-by-count":22,"title":["Antiphospholipid antibody syndrome: Rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies"],"prefix":"10.1067","volume":"139","author":[{"given":"Aaron","family":"Tomer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mlc.2002.121551_bib1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.1997.03540430061034","article-title":"Antiphospholipid antibody","volume":"227","author":"Lockshin","year":"1997","journal-title":"JAMA"},{"key":"10.1067\/mlc.2002.121551_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199707173370303","article-title":"Pregnancy loss in the antiphospholipid-antibody syndrome: a possible thrombogenic mechanism","volume":"337","author":"Rand","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mlc.2002.121551_bib3","unstructured":"Triplet DA. Lupus anticoagulants\/phospholipid-dependent antibodies: pathophysiology. The Scientific and Standardization Committee on Lupus Anticoagulants\/Phospholipid-Dependent Antibodies. Proceedings of the 45th meeting of the International Society on Thrombosis and Haemostasis; 1999 Aug; Washington, DC."},{"key":"10.1067\/mlc.2002.121551_bib4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-0037-1614601","article-title":"Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thronbophilia (ECAT) survey using plasma spiked with monoclonal antibodies against human \u03b22-glycoprotein I","volume":"81","author":"Arnout","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1067\/mlc.2002.121551_bib5","unstructured":"Taylor JM. The Fifth International Survey on Lupus Anticoagulants (ISLA-5). Scientific and Standardization Committee. Proceedings of the 45th meeting of the International Society on Thrombosis and Haemostasis. 1999 Aug; Washington, DC."},{"key":"10.1067\/mlc.2002.121551_bib6","first-page":"53","article-title":"Inability to distinguish between thrombotic and nonthrombotic antiphospholipid antibody positive patients with kaolin clotting time and diluted Russell's viper venom assay ratio [abstract]","volume":"5","author":"Callahan","year":"1996","journal-title":"Lupus"},{"key":"10.1067\/mlc.2002.121551_bib7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(88)80229-8","article-title":"Clinical significance of a single test for anti-cardiolipin antibodies in patients with SLE","volume":"85","author":"Kalunian","year":"1988","journal-title":"Am J Med"},{"key":"10.1067\/mlc.2002.121551_bib8","first-page":"462","article-title":"Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: maternal and fetal complications and management","volume":"2","author":"Ruiz-Irastorza","year":"2000","journal-title":"Isr Med Assoc J"},{"key":"10.1067\/mlc.2002.121551_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ajh.2830130204","article-title":"Chlorpromazine-induced lupus anticoagulant and associated imunologic abnormalities","volume":"13","author":"Canoso","year":"1982","journal-title":"Am J Hematol"},{"key":"10.1067\/mlc.2002.121551_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0143-4004(05)80407-2","article-title":"The expression of the placental protein, annexin V, by villous trophoblast: immunolocalization and in vitro coagulation","volume":"15","author":"Krikun","year":"1994","journal-title":"Placenta"},{"key":"10.1067\/mlc.2002.121551_bib11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/0002-9378(94)90403-0","article-title":"Reduction of annexin V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion","volume":"171","author":"Rand","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mlc.2002.121551_bib12","first-page":"73","article-title":"Displacement of factor Va by annexin V","author":"Andree","year":"1992"},{"key":"10.1067\/mlc.2002.121551_bib13","first-page":"17420","article-title":"Binding of annexin V\/placental anticoagulant protein I to platelets","volume":"265","author":"Thiagarajan","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1067\/mlc.2002.121551_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/096120339600500515","article-title":"Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss?","volume":"5","author":"Branch","year":"1996","journal-title":"Lupus"},{"key":"10.1067\/mlc.2002.121551_bib15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary criteria for definite antiphospholipid syndrome","volume":"42","author":"Willson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mlc.2002.121551_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1365-2141.1997.2613077.x","article-title":"Rapid, sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia (HIT)","volume":"98","author":"Tomer","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1067\/mlc.2002.121551_bib17","first-page":"1531","article-title":"In vivo platelet receptor activation and membrane procoagulant activity determined by flow cytometry [abstract]","volume":"69","author":"Tomer","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1067\/mlc.2002.121551_bib18","first-page":"1577","article-title":"Effects of rhGM-CSF on platelet survival and activation using a non-human primate model","volume":"21","author":"Tomer","year":"1993","journal-title":"Exp Hematol"},{"key":"10.1067\/mlc.2002.121551_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<53::AID-AJH10>3.0.CO;2-F","article-title":"Determination of heparin-induced thrombocytopenia (HIT): a rapid flow cytometric assay (FCA) for direct demonstration of antibody-mediated platelet activation","volume":"61","author":"Tomer","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1067\/mlc.2002.121551_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"Tomer","year":"2001","journal-title":"J Lab Clin Med."},{"key":"10.1067\/mlc.2002.121551_bib21","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thromb Haemost."},{"key":"10.1067\/mlc.2002.121551_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0140-6736(93)91477-4","article-title":"The antiphospholipid syndrome: ten years on","volume":"342","author":"Hughes","year":"1993","journal-title":"Lancet"},{"key":"10.1067\/mlc.2002.121551_bib23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulant: an update on behalf of the subcommittee on lupus anticoagulant\/antiphospholipid antibody of the Scientific and Stratification Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1067\/mlc.2002.121551_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardilipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clnical significance","volume":"112","author":"Love","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1067\/mlc.2002.121551_bib25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"10.1067\/mlc.2002.121551_bib26","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: \u03b22-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNiel","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mlc.2002.121551_NEWBIB1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajh.2830470112","article-title":"Anti\u2014annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and\/or anticardiolipin antibody","volume":"47","author":"Matsuda","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1067\/mlc.2002.121551_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0049-3848(94)90145-7","article-title":"Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia","volume":"75","author":"Matsuda","year":"1994","journal-title":"Thromb Res"},{"key":"10.1067\/mlc.2002.121551_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0037-1614001","article-title":"Antiphospholipid and antiprotein syndrome in non-thrombotic, non-autoimmune women with unexplained recurrent primary early fetal loss. The Nimes Obstetricians and Haematologists Study-NOHA","volume":"84","author":"Gris","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1067\/mlc.2002.121551_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<209::AID-AJH6>3.0.CO;2-#","article-title":"Clinical significance of anti\u2014annexin V antibodies in patients with systemic lupus erythematosus","volume":"54","author":"Kaburaki","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1067\/mlc.2002.121551_bib31","first-page":"2168","article-title":"Anti-annexin antibodies and digital ischemia in patients with scleroderma","volume":"26","author":"Sugiura","year":"1999","journal-title":"J Hematol"},{"key":"10.1067\/mlc.2002.121551_bib32","first-page":"1715","article-title":"Detection of anti\u2014annexin IV and V antibodies in patients with antiphospholipid symdrome and systemic lupus erythematosus","volume":"26","author":"Satoh","year":"1999","journal-title":"J Rheum"},{"key":"10.1067\/mlc.2002.121551_bib33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1006\/bbrc.1994.2833","article-title":"Lupus anticoagulant antibodies induce apoptosis in umbilical vein endothelial cells: involvement of annexin V","volume":"205","author":"Nakamura","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1067\/mlc.2002.121551_bib34","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0002-9378(99)70674-5","article-title":"Annexin V is critical in the maintenance of murine placental integrity","volume":"180","author":"Wang","year":"1999","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Laboratory and Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022214302113928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022214302113928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T22:42:00Z","timestamp":1576449720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022214302113928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0022214302113928"],"URL":"https:\/\/doi.org\/10.1067\/mlc.2002.121551","relation":{},"ISSN":["0022-2143"],"issn-type":[{"value":"0022-2143","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}